Company Profile

Intelligent Bio-Systems Inc (AKA: IBS)
Profile last edited on: 9/3/19      CAGE: 46RB7      UEI:

Business Identifier: DNA sequencing system
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

34 Bear Hill Road
Waltham, MA 02451
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

In June 2012, Intelligent Bio-Systems Inc was acquired by Quiagen N.V., a large life sciences research tools company. Intelligent Bio-Systems is developing new biochemical and instrumentation technologies related to DNA and RNA analysis for research and diagnostic applications: NGS instruments for applications in clinical research and molecular diagnostics. IBS has licensed technology from Columbia University for the low-cost, high-throughput sequencing of DNA segments

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2013 2 NIH $3,502,953
Project Title: Novel Diagnostic Sequencing System for HIV Resistance Testing
2013 2 NIH $1,719,004
Project Title: Digital Gene Expression for Cancer
2012 2 NIH $1,638,683
Project Title: Novel Cleavable Nucleotides for DNA Sequencing by Synthesis
2011 2 NIH $3,229,278
Project Title: Ordered Arrays for Advanced Sequencing Systems
2009 2 NIH $1,632,915
Project Title: Streamlined Template Preparation for Advanced Sequencing Methods

Key People / Management

  Steven J Gordon -- President